WO2024246857 - UREA COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ASTHMA AND PARKINSON'S DISEASE
National phase entry is expected:
Publication Number
WO/2024/246857
Publication Date
05.12.2024
International Application No.
PCT/IB2024/055345
International Filing Date
31.05.2024
Title **
[English]
UREA COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING ASTHMA AND PARKINSON'S DISEASE
[French]
COMPOSÉS ET COMPOSITIONS D'URÉE ET MÉTHODES DE TRAITEMENT DE L'ASTHME ET DE LA MALADIE DE PARKINSON
Applicants **
INNOPHARMASCREEN INC.
28 FL, V689, 165, Convensia-daero
Yeonsu-gu
Incheon 21988, KR
Inventors
KANG, Incheol
602-1204, 96, Convensia-daero 42 beon-gil
Yeonsu-gu
Incheon 22001, KR
SEO, Seung Oh
2-402, 9, Songdomirae-ro
Yeonsu-gu
Incheon 21988, KR
Priority Data
63/470,650
02.06.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
MOIP
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1245 | |
| EPO | Filing, Examination | 7318 | |
| Japan | Filing | 532 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3235 |
Total: 12905 USD
Abstract[English]
Disclosed are compounds of the following structure (I): or a pharmaceutically acceptable salt thereof, pharmaceutical compositions of the compounds or salts, and their use for treating asthma or Parkinson's disease.[French]
L'invention concerne des composés de la structure suivante : ou un sel pharmaceutiquement acceptable de ceux-ci, des compositions pharmaceutiques des composés ou des sels, et leur utilisation pour le traitement de l'asthme ou de la maladie de Parkinson.